This network meta-analysis was performed to investigate the association between the use of DPP-4i, GLP-1 RAs, or SGLT-2i and the risk of fracture among patients with T2DM by synthesizing the data from all available randomized controlled trials (RCTs). This evidence concerns the gene GLP1R and type 2 diabetes mellitus.